“Treatment with oral tofacitinib is potentially a new treatment option for patients with moderate to severe ulcerative colitis, pending review by the [U.S. Food and Drug Administration],” Sandborn said.The study was funded by Pfizer, Inc., the maker of arthritis treatment drug. Sandborn said he has received research grants from the company and served as a consultant for Pfizer.Whether arthritis treatment drug that eliminate Ulcerative Colitis Symptoms should be used as a first treatment is still not clear, said Dr. Arun Swaminath, director of the inflammatory bowel disease program at Lenox Hill Hospital in New York City.
Because arthritis treatment drug comes as a pill, it could have an advantage for patients and eliminate Ulcerative Colitis Symptoms , Swaminath said. But so far it has only been tried with patients who have not responded to other treatments, he said.”How it is used in the real world may be different than how it was used in these studies,” Swaminath said. “I am not going out on a limb and say this should be the first choice, because we don’t have enough data to say that’s the way it should be positioned.